As macroprolactinomas are associated with longer lasting hyperprolactinemia and related hypogonadism (34, 35), the significantly higher rates of baseline PRL levels in the EO cohort probably reflect on the longer disease duration in more oligosymptomatic men (36, 37). This evidence concerns the gene PRL and hyperprolactinemia.